Company: ZVRA
Filing Date: 2025-11-20
Form Type: 8-K
Source: 0001193125-25-289865
Chunk: 2

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-11-20
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits

  Exhibit      Description                                                                  
      No.                                                                                   
     99.1      Press Release dated November 20, 2025.                                       
 ────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                               Zevra Therapeutics, Inc.                                                               
  Date: November 20, 2025      By:                           /s/ Timothy J. Sangiovanni                               
                                                             Timothy J. Sangiovanni, CPA                              
                                                             Senior Vice President, Finance and Corporate Controller